allan-herndon-dudley syndrome |
Disease ID | 625 |
---|---|
Disease | allan-herndon-dudley syndrome |
Definition | A rare, X-linked recessive inherited syndrome caused by mutations in the SLC16A2 (MCT8) gene. It affects exclusively males and is characterized by mental retardation, limited mobility, muscle hypoplasia, hypotonia, contractures, and spasticity. |
Synonym | ahds allan-herndon syndrome allan-herndon-dudley syndrome (ahds) mct8 (slc16a2)-specific thyroid hormone cell transporter deficiency mental retardation and muscular atrophy mental retardation, x-linked, with hypotonia monocarboxylate transporter 8 (mct8) deficiency monocarboxylate transporter 8 deficiency monocarboxylate transporter 8 deficiency (disorder) monocarboxylate transporter-8 deficiency t3 resistance triiodothyronine resistance x-linked mental retardation with hypotonia |
Orphanet | |
OMIM | |
DOID | |
UMLS | C0795889 |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:3) |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:15) 6900 | CNTN2 | 2.12 | DISEASES 117154 | DACH2 | 3.97 | DISEASES 1741 | DLG3 | 2.713 | DISEASES 80712 | ESX1 | 2.364 | DISEASES 4356 | MPP3 | 3.317 | DISEASES 5077 | PAX3 | 1.535 | DISEASES 5080 | PAX6 | 1.289 | DISEASES 7849 | PAX8 | 2.368 | DISEASES 5230 | PGK1 | 2.011 | DISEASES 5329 | PLAUR | 2.159 | DISEASES 117247 | SLC16A10 | 5.926 | DISEASES 23428 | SLC7A8 | 3.527 | DISEASES 53919 | SLCO1C1 | 5.415 | DISEASES 7068 | THRB | 1.804 | DISEASES 9203 | ZMYM3 | 3.438 | DISEASES |
Locus | Symbol | Locus(Total Locus:1) SLC16A2 | Xq13.2 |
Disease ID | 625 |
---|---|
Disease | allan-herndon-dudley syndrome |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:59) HP:0010864 | Intellectual disability, severe HP:0000767 | Funnel chest HP:0000520 | Proptosis HP:0002307 | Sialorrhea HP:0001258 | Spastic paraplegia, lower limb HP:0000020 | Urinary incontinence HP:0006887 | Intellectual disability, progressive HP:0000464 | Abnormality of the neck HP:0001344 | Absent speech HP:0000508 | Ptosis HP:0002305 | Involuntary writhing movements HP:0000821 | Underactive thyroid HP:0000582 | Upslanted palpebral fissure HP:0007598 | Bilateral single transverse palmar creases HP:0001251 | Ataxia HP:0010669 | Cheekbone underdevelopment HP:0008583 | Underfolded superior helices HP:0010864 | Early and severe mental retardation HP:0002925 | Increased serum thyroid-stimulating hormone HP:0011344 | Severe global developmental delay HP:0002188 | Delayed CNS myelination HP:0000194 | Open mouth HP:0006887 | Progressive mental retardation HP:0009004 | Hypoplasia of the musculature HP:0008872 | Feeding difficulties in infancy HP:0100651 | Type I diabetes mellitus HP:0002415 | Degeneration of white matter of brain HP:0000252 | Small head circumference HP:0001288 | Gait disturbance HP:0001822 | Hallux valgus HP:0002607 | Bowel incontinence HP:0000400 | Large ears HP:0002650 | Scoliosis HP:0002169 | Clonus HP:0000275 | Narrow face HP:0100022 | Abnormality of movement HP:0000395 | Prominent antihelix HP:0002514 | Cerebral calcification HP:0003700 | Diffuse muscle wasting HP:0002540 | Inability to walk HP:0000411 | Protruding ear HP:0001583 | Rotatory Nystagmus HP:0001371 | Flexion contractures of joints HP:0001347 | Hyperreflexia HP:0000341 | Narrow bitemporal diameter HP:0000549 | Abnormal conjugate eye movement HP:0002510 | Spastic quadriplegia HP:0001387 | Joint stiffness HP:0004422 | Biparietal narrowing HP:0000400 | Macrotia HP:0001763 | Pes planus HP:0000737 | Irritability HP:0003487 | Extensor plantar reflexes HP:0100490 | Camptodactyly of finger HP:0001260 | Dysarthric speech HP:0002381 | Aphasia HP:0100015 | Spock ear HP:0001319 | Hypotonia, in neonatal onset HP:0003202 | Skeletal muscle atrophy |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:6) |
Disease ID | 625 |
---|---|
Disease | allan-herndon-dudley syndrome |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Manually Genotypes:1) | |||
---|---|---|---|
Gene | Mutation | DOI | Article Title |
SLC16A2 | - | doi:10.1038/gim.2015.51 | Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:22) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs104894931 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74529355 | T | C |
rs104894936 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74521008 | C | A,T |
rs104894938 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74531414 | T | C |
rs104894939 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74525802 | T | G |
rs104894940 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74525844 | C | A |
rs113994162 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74421996 | C | T |
rs113994164 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74529320 | CTT | - |
rs113994166 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74531545 | C | - |
rs122455132 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74529232 | T | C |
rs367543059 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74529295 | T | C |
rs387906501 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74521020 | TCT | - |
rs587784382 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74524699 | C | T |
rs587784383 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74524762 | G | A |
rs587784384 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74525834 | C | T |
rs587784386 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74421914 | C | T |
rs766773277 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74524723 | C | A |
rs794726932 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74421963 | G | A |
rs794726933 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74421990 | A | C |
rs797045962 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74529434 | - | C |
rs797045963 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2 | X | 74531407 | GTAATCCT | - |
rs797045965 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74421893 | C | - |
rs797045966 | NA | 6567 | SLC16A2 | umls:C0795889 | CLINVAR | NA | 0.565700279 | NA | SLC16A2;LOC105373252 | X | 74422011 | A | - |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:16) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002540 | Inability to walk | MP:0013294 | prenatal lethality prior to heart atrial septation | death prior to the completion of heart atrial septation (Mus: E14.5-15.5) |
HP:0008872 | Feeding difficulties in infancy | MP:0011075 | abnormal macrophage activation involved in immune response | anomaly in the process in which a change in response and behavior of a macrophage results from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response |
HP:0001319 | Neonatal hypotonia | MP:0004144 | hypotonia | decreased muscle tension resulting in limpness of the muscles in the resting state, not to be confused with weakness |
HP:0001387 | Joint stiffness | MP:0003098 | decreased tendon stiffness | reduced ability of tendon to maintain tensile strength and load |
HP:0100490 | Camptodactyly of finger | MP:0020010 | decreased bone mineral density of femur | reduction in the quatitative measurment value of mineral content of bone in the long bone of the thigh |
HP:0000464 | Abnormality of the neck | MP:0009536 | abnormal interstitial cell of Cajal morphology | any structural anomaly in the type of cell found in the gastrointestinal tract and serving as a pacemaker that triggers gut contraction; ICCs mediate inputs from the enteric nervous system to smooth muscle cells and are thought to be the cells from which |
HP:0100651 | Type I diabetes mellitus | MP:0004803 | increased susceptibility to autoimmune diabetes | greater likelihood that an organism will develop inflammatory pancreatic disease resulting from the body attacking and destroying the insulin-producing beta islet cells of the pancreas |
HP:0006887 | Intellectual disability, progressive | MP:0000748 | progressive muscle weakness | increasing loss of muscle strength over time |
HP:0003202 | Skeletal muscle atrophy | MP:0014068 | abnormal muscle glycogen level | the normal concentration of a readily converted carbohydrate reserve in muscle tissue |
HP:0010669 | Hypoplasia of the zygomatic bone | MP:0011205 | excessive folding of visceral yolk sac | the appearance of wrinkles or folds on the surface of the visceral yolk sac |
HP:0100022 | Abnormality of movement | MP:0005223 | abnormal dorsal-ventral polarity of the somites | anomalous development or formation of the pattern of somites along the axis that runs from the front (ventral) to the back (dorsal) surface of the body |
HP:0000582 | Upslanted palpebral fissure | MP:0012535 | abnormal optic fissure closure | failure to initiate and/or complete closure of the transient gap in the ventral margin of the developing optic cup; fusion of the optic fissure begins with apposition of the inferior lips of the ventral-most optic cup and continues anteriorly toward its r |
HP:0000020 | Urinary incontinence | MP:0003280 | urinary incontinence | inability to control the urinary bladder excretory functions leading to involuntary urination |
HP:0011344 | Severe global developmental delay | MP:0002084 | abnormal developmental patterning | abnormal systematic arrangement of the developing body along an axis |
HP:0000411 | Protruding ear | MP:0005105 | abnormal middle ear ossicle morphology | any structural anomaly of the three small bones of the middle ear |
HP:0002925 | Thyroid-stimulating hormone excess | MP:0005468 | abnormal thyroid hormone level | aberrant concentration of any of the hormones secreted by the thyroid gland |
Mapped by homologous gene(Total Items:56) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0007598 | Bilateral single transverse palmar creases | MP:0012279 | wide sternum | an increase in the width of the long flat bone of the chest that articulates with the clavicle and first seven rib pairs |
HP:0001258 | Spastic paraplegia | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
HP:0009004 | Hypoplasia of the musculature | MP:0011100 | preweaning lethality, complete penetrance | death of all organisms of a given genotype in a population between fertilization and weaning age (Mus: approximately 3-4 weeks of age) |
HP:0002307 | Drooling | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0002650 | Scoliosis | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0011344 | Severe global developmental delay | MP:0020157 | abnormal behavioral response to alcohol | any anomaly in the behavioral response induced by alcohol, such as induced hyperactivity or stereotypic behavior |
HP:0001344 | Absent speech | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000411 | Protruding ear | MP:0020157 | abnormal behavioral response to alcohol | any anomaly in the behavioral response induced by alcohol, such as induced hyperactivity or stereotypic behavior |
HP:0002381 | Aphasia | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0000508 | Ptosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000275 | Narrow face | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0001288 | Gait disturbance | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0001347 | Hyperreflexia | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0003202 | Skeletal muscle atrophy | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0001371 | Flexion contracture | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0003700 | Generalized amyotrophy | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0001319 | Neonatal hypotonia | MP:0020214 | susceptible to malignant hyperthermia | increased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine |
HP:0006887 | Intellectual disability, progressive | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0002415 | Leukodystrophy | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0100022 | Abnormality of movement | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0000549 | Abnormal conjugate eye movement | MP:0010088 | decreased circulating fructosamine level | decrease in the concentration in the blood of total non enzymatic glycated proteins in the blood |
HP:0001583 | Rotary nystagmus | MP:0013438 | dysmyelination | reduced amount of myelin present in the form of a myelin sheath surrounding an axon due to defects in the synthesis and formation of myelin |
HP:0002510 | Spastic tetraplegia | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0000821 | Hypothyroidism | MP:0020169 | increased thyroid gland weight | higher than average weight of the thyroid gland |
HP:0002540 | Inability to walk | MP:0014178 | increased brain apoptosis | increase in the number of cells of the brain undergoing programmed cell death |
HP:0001260 | Dysarthria | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0002169 | Clonus | MP:0013401 | increased endometrial gland number | greater than normal numbers of the simple or branched tubular glands found in the mucus membrane of the uterus |
HP:0002305 | Athetosis | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0100490 | Camptodactyly of finger | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0002188 | Delayed CNS myelination | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0000582 | Upslanted palpebral fissure | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000737 | Irritability | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0000767 | Pectus excavatum | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000020 | Urinary incontinence | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0001822 | Hallux valgus | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0100651 | Type I diabetes mellitus | MP:0020220 | decreased tear production | decreased production of the amount of fluid produced in the eye |
HP:0000194 | Open mouth | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000520 | Proptosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000395 | Prominent antihelix | MP:0013026 | decreased Ly6C low monocyte number | decrease in the number of monocytes that express low levels of Ly6C and low MHC class II that represent a subset of patrolling monocytes |
HP:0008583 | Underfolded superior helices | MP:0010069 | increased serotonin level | increase in the amount of biochemical messenger and regulator, found in the CNS, gastrointestinal tract, and produced by platelets that mediates neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity |
HP:0010864 | Intellectual disability, severe | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0001251 | Ataxia | MP:0020301 | short tongue | decreased length of the mobile mass of muscular tissue and surrounding epithelial tissue occupying the cavity of the mouth and forming part of the floor |
HP:0008872 | Feeding difficulties in infancy | MP:0020214 | susceptible to malignant hyperthermia | increased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine |
HP:0100015 | Stahl ear | MP:0011967 | increased or absent threshold for auditory brainstem response | increase in the value at which one or more sound frequencies or broadband clicks first elicits a recordable response generated by electrical activity of neurons in the ascending auditory system, or complete lack of a recordable response at any frequency o |
HP:0002607 | Bowel incontinence | MP:0013438 | dysmyelination | reduced amount of myelin present in the form of a myelin sheath surrounding an axon due to defects in the synthesis and formation of myelin |
HP:0002514 | Cerebral calcification | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0004422 | Biparietal narrowing | MP:0012431 | increased lymphoma incidence | greater than the expected number of neoplasms characterized by a proliferation of malignant lymphocytes in lymphoid tissue in a specific population in a given time period |
HP:0002925 | Thyroid-stimulating hormone excess | MP:0020169 | increased thyroid gland weight | higher than average weight of the thyroid gland |
HP:0001387 | Joint stiffness | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0000400 | Macrotia | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0001763 | Pes planus | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0003487 | Babinski sign | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0010669 | Hypoplasia of the zygomatic bone | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000341 | Narrow forehead | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000464 | Abnormality of the neck | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000252 | Microcephaly | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
Disease ID | 625 |
---|---|
Disease | allan-herndon-dudley syndrome |
Case | (Waiting for update.) |